Literature DB >> 16297877

Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha.

Hyunghee Lee1, Frank J Gonzalez, Michung Yoon.   

Abstract

We investigated whether ginseng regulates lipoprotein metabolism by altering peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated pathways, using a PPARalpha-null mouse model. Administration of ginseng extract, ginsenosides, and ginsenoside Rf (Rf) to wild-type mice not only significantly increased basal levels of hepatic apolipoprotein (apo) A-I and C-III mRNA compared with wild-type controls, but also substantially reversed the reductions in mRNA levels of apo A-I and C-III expected following treatment with the potent PPARalpha ligand Wy14,643. In contrast, no effect was detected in the PPARalpha-null mice. Testing of eight main ginsenosides on PPARalpha reporter gene expression indicated that Rf was responsible for the effects of ginseng on lipoprotein metabolism. Furthermore, the inhibition of PPARalpha-dependent transactivation by Rf seems to occur at the level of DNA binding. These results demonstrate that ginseng component Rf regulates apo A-I and C-III mRNA and the actions of Rf on lipoprotein metabolism are mediated via interactions with PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297877     DOI: 10.1016/j.bbrc.2005.10.197

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  The role of complementary and alternative medicine in diabetes.

Authors:  Shefali Dham; Viral Shah; Sondra Hirsch; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

2.  Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysis.

Authors:  Chunhao Yu; Chong-Zhi Wang; Chun-Jie Zhou; Bin Wang; Lide Han; Chun-Feng Zhang; Xiao-Hui Wu; Chun-Su Yuan
Journal:  J Pharm Biomed Anal       Date:  2014-07-01       Impact factor: 3.935

3.  Comparative studies of saponins in 1-3-year-old main roots, fibrous roots, and rhizomes of Panax notoginseng, and identification of different parts and growth-year samples.

Authors:  Xiu-Hong Jia; Chao-Qun Wang; Jin-Huai Liu; Xiao-Wei Li; Xuan Wang; Ming-Ying Shang; Shao-Qing Cai; Shu Zhu; Katsuko Komatsu
Journal:  J Nat Med       Date:  2012-07-28       Impact factor: 2.343

4.  The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type 2 diabetes.

Authors:  Hai-xiang Ni; Ning-juan Yu; Xue-hui Yang
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

Review 5.  The potential of natural products for targeting PPARα.

Authors:  Daniela Rigano; Carmina Sirignano; Orazio Taglialatela-Scafati
Journal:  Acta Pharm Sin B       Date:  2017-06-16       Impact factor: 11.413

6.  Ginsenoside Rf inhibits cyclooxygenase-2 induction via peroxisome proliferator-activated receptor gamma in A549 cells.

Authors:  Heewon Song; Joonwoo Park; KeunOh Choi; Jeonggeun Lee; Jie Chen; Hyun-Ju Park; Byeung-Il Yu; Mitsuru Iida; Mee-Ra Rhyu; YoungJoo Lee
Journal:  J Ginseng Res       Date:  2018-11-30       Impact factor: 6.060

7.  Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling.

Authors:  Dahye Yoon; Bo-Ram Choi; Young-Chang Kim; Seon Min Oh; Hyoung-Geun Kim; Jang-Uk Kim; Nam-In Baek; Suhkmann Kim; Dae Young Lee
Journal:  Biomolecules       Date:  2019-08-28

8.  Anti-melanogenic property of ginsenoside Rf from Panax ginseng via inhibition of CREB/MITF pathway in melanocytes and ex vivo human skin.

Authors:  Ha-Ri Lee; Joon Min Jung; Ji-Yeon Seo; Sung Eun Chang; Youngsup Song
Journal:  J Ginseng Res       Date:  2020-12-09       Impact factor: 6.060

9.  Therapeutic potential of ginsenoside Rg3 and Rf for Huntington's disease.

Authors:  Mijung Lee; Jae-Jun Ban; Bo Hee Won; Wooseok Im; Manho Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-06-14       Impact factor: 2.416

10.  The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase.

Authors:  Li-Peng Jiang; Jin Zhao; Yun-Feng Cao; Mo Hong; Dong-Xue Sun; Xiao-Yu Sun; Jun Yin; Zhi-Tu Zhu; Zhong-Ze Fang
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-29       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.